National Health Investors Inc (NYSE:NHI) Expected to Announce Quarterly Sales of $79.81 Million


Equities research analysts expect National Health Investors Inc (NYSE:NHI) to post sales of $79.81 million for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for National Health Investors’ earnings, with the lowest sales estimate coming in at $78.06 million and the highest estimate coming in at $80.82 million. National Health Investors posted sales of $74.92 million during the same quarter last year, which would indicate a positive year over year growth rate of 6.5%. The business is scheduled to report its next earnings report on Tuesday, November 5th.

According to Zacks, analysts expect that National Health Investors will report full year sales of $312.60 million for the current year, with estimates ranging from $305.00 million to $317.55 million. For the next year, analysts expect that the business will post sales of $332.97 million, with estimates ranging from $320.96 million to $345.10 million. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that follow National Health Investors.

National Health Investors (NYSE:NHI) last issued its earnings results on Thursday, August 8th. The real estate investment trust reported $0.92 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.37 by ($0.45). The business had revenue of $78.10 million for the quarter, compared to analyst estimates of $77.64 million. National Health Investors had a return on equity of 11.00% and a net margin of 50.71%. The firm’s revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.38 EPS.

Separately, Zacks Investment Research lowered shares of National Health Investors from a “hold” rating to a “sell” rating in a research report on Saturday. Three research analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $79.60.

National Health Investors stock opened at $81.77 on Wednesday. National Health Investors has a fifty-two week low of $70.54 and a fifty-two week high of $84.75. The company has a debt-to-equity ratio of 1.04, a quick ratio of 14.42 and a current ratio of 14.42. The stock has a market cap of $3.58 billion, a P/E ratio of 14.92, a price-to-earnings-growth ratio of 3.81 and a beta of 0.33. The firm’s fifty day moving average price is $81.61 and its 200-day moving average price is $79.09.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 8th. Stockholders of record on Monday, September 30th will be given a dividend of $1.05 per share. The ex-dividend date of this dividend is Friday, September 27th. This represents a $4.20 annualized dividend and a dividend yield of 5.14%. National Health Investors’s dividend payout ratio (DPR) is presently 76.64%.

In related news, CIO Kevin Carlton Pascoe sold 900 shares of the business’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $82.46, for a total value of $74,214.00. Following the completion of the sale, the executive now owns 27,826 shares in the company, valued at approximately $2,294,531.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 5.11% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the stock. Marshall Wace North America L.P. bought a new position in shares of National Health Investors during the first quarter valued at about $31,000. Farmers National Bank purchased a new stake in National Health Investors during the 1st quarter valued at about $49,000. Krane Funds Advisors LLC purchased a new stake in National Health Investors during the 2nd quarter valued at about $58,000. Doyle Wealth Management bought a new position in National Health Investors during the 2nd quarter worth approximately $78,000. Finally, Tower Research Capital LLC TRC grew its position in National Health Investors by 648.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 2,259 shares of the real estate investment trust’s stock worth $176,000 after acquiring an additional 1,957 shares during the last quarter. 69.71% of the stock is currently owned by institutional investors.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

See Also: What is an Initial Coin Offering (ICO)?

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for National Health Investors and related companies with MarketBeat.com’s FREE daily email newsletter.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here